Policy & Regulation: Page 27

PharmaVoice Team/PharmaVoice

Courting Resolution

By Kim Ribbink Product Litigation is Straining the Industry Product litigation has become an onerous fact of life for the pharmaceutical industry. Roughly 50 products are currently under active litigation in the United States, according to various industry sources. Legal experts say it’s not so m...
By Kim Ribbink • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

UpFront

Star Volunteer Sharon Callahan, president of Summit Grey, has been named as the 2006 HBA Star Volunteer by the Healthcare Businesswomen’s Association (HBA). Aside from leading the interactive agency, Ms. Callahan dedicates much of her time to HBA activities. She began her involvement in 1989 and ...
By PharmaVoice Team • Jan. 2, 2008
Explore the Trendline➔

Stock via Getty Images

Trendline

Commercialization, marketing and social media

As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff
PharmaVoice Team/PharmaVoice

Drugs in the Real World

By Denise Myshko A greater regulatory focus on safety means companies are under pressure to provide more information about a prescription drug, as well as about the characteristics of patients, once a product becomes available to the larger marketplace. companies are being asked to provide inform...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Salesforce of the Future

With a plethora of obstacles to overcome — from busy doctors to Medicare to reimbursement — the sales rep of the future will not only need knowledge of the product and disease state but will need to be skilled in the art of relationship building and must become a true partner to physicians. By Ki...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

What's New

New Prescription Drug Information Format to Improve Patient Safety The FDA is seeking to reduce the complexity of information on prescription drug labels, making them more useful for physicians and patients. The U.S. Food and Drug Administration (FDA) has unveiled a major revision to the format o...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Prescription for Success in Globalization

Prescription for Success in Globalization VIEW on a common global language Sig Shirodkar, Principal, and Mark Mozeson, Principal and life sciences Practice Leader, both of Archstone Consulting, discuss why designing a set of corporate attributes and standards of behavior is the key to global succ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

Regulatory Deficiency is High Among Non-U.S. Clinical Investigators In a sharp reversal of previous trends, good clinical practice (GCP) deficiency rates for non-U.S.-based clinical investigators have surged past the corresponding rates for U.S.-based investigators. This is the finding of The Glo...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

UpFront

Device Trends Source: Booz Allen Hamilton Inc., New York Five Issues Expected to Shape the Industry In 2005, the device industry registered an average 12% growth in sales over 2004, with a few companies growing as much as 25%. Smaller industry players were buoyed by the Medical Device User Fee St...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

On the Cover Bridging the gap between sales and marketing One of the most challenging issues facing sales and marketing departments in life-sciences companies is integrating their internal communications for optimal product messaging. By working at senior levels to create a single vision for sale...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

E-Media

Skyscape Releases Mobile Drug Usage Reference Software Skyscape Inc. has released FamilyRx: AHFS Patient Drug Information, a mobile medical reference that places trusted, up-to-date information on proper medication usage into the hands of patients and their families. FamilyRx is available for use...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

Converting Service Channels Into Sales Channels Promises Profit Growth Faced with escalating market demands to produce greater returns from existing corporate assets, executives at leading Fortune 500 organizations are increasingly converting traditional service channels into high-performance sal...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Talent Pool

Pharma POOL Robert H. Armstrong Dr. Steven Caffe Baxter Names VPs Baxter International, a healthcare company in Deerfield, Ill., has appointed Robert H. Armstrong to the newly created position of VP, research and development, medical devices and adjacent disposables. He is responsible for develop...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Managing Marketing Under Medicare Part D

Medicare Part D presents many opportunities, as well as challenges, for pharmaceutical marketers. As the industry adapts its marketing strategies for this evolving arena, transparency is a top priority. Brand teams also need to remain flexible and stay on top of emerging information and trends to...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Talent Pool

Pharma POOL Herm Cukier Terrence Moore Organon Adds Staff Organon, the human healthcare business unit of Akzo Nobel, Arnhem, the Netherlands, has appointed Herm Cukier as executive VP of global marketing. Based in Organon’s Roseland, N.J., headquarters, Mr. Cukier leads worldwide marketing activi...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Sense and Sensibility -- Pamela Williamson Joyce

With a wide and deep understanding of the inner sanctum of numerous departments in the life sciences, Pamela Williamson Joyce has been able to bring both inventiveness and clear-headed thinking to Serono’s regulatory practice, helping the company to bring many new products to market. The path to ...
By Kim Ribbink • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

Table of Contents January 2006 On the Cover Competitive intelligence: The eyes and ears of the industry Shrinking pipelines, increased regulatory scrutiny, and the emergence of clinical-trial registries are just a few of the factors that are creating a tougher environment for industry players and...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

HBA Unleashes the Power of Being

Becoming an Agent of Change Was the Focus of the 2005 Leadership Conference by Marie Tartaglio, M.Ed., Director, Training & Learning Strategy, Scientific Advantage LLC, and Donna Ramer, President, StrategCations Inc., Member, HBA Board of Directors “Successful leaders are adept at mastering c...
By Marie Tartaglio • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

Ringing in a new year of change Taren Grom, Editor of PharmaVOICE, and Mary Alice Raudenbush, VP of Regulatory Affairs at Endo Pharmaceuticals, share a moment during the recent HBA Leadership Conference in Baltimore, the focus of which was becoming an agent of change. HBA Leadership Conference Ri...
By Taren Grom • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Talent Pool

Executive Appointments and Promotions November 2005 Talent Pool Pharma POOL Lamberto Andreotti Bristol-Myers Squibb Promotes President, Worldwide Pharmaceuticals Bristol-Myers Squibb has promoted Lamberto Andreotti to executive VP and president of Worldwide Pharmaceuticals. Based in New York, Bri...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

What's New

i3 Creates Drug Safety Business The new business unit is responding to the industry’s need for greater vigilance regarding the safety of drugs. i3 has introduced i3 Drug Safety, a new business unit created to unite all of the organization’s epidemiology and drug-safety resources into one unit to ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

PharmaTrax Cardiovascular Drug Market to Top $100 Billion by 2008 The worldwide market for prescription cardiovascular medications, which topped $75 billion in 2004, will surpass the $100 billion mark by 2008, according to a new report released by Kalorama Information titled The Worldwide M...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Medicare Part D And Its Market Effects

Medicare Part D And Its Market Effects Medicare Part D Larry Olson, Director, Healthcare, Consumer Practice Area In just a few months, the prescription drug market will experience unprecedented change. When Part D of the Medicare Prescription Drug, Improvement and Modernization Act (MM...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

Letter from the Editor The Forum Marketing’s New Frontiers: Changing market dynamics, new regulations, ongoing public scrutiny, and evolving technology platforms are some of the challenges that today’s pharmaceutical marketers must overcome to meet their company’s corporate goals. Company Listing...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Meeting the New Guidelines and Grantor Needs: Adapt, Comply, or Die

Regulatory Guidelines Meeting the New Guidelines and Grantor Needs: Adapt, Comply, or Die Brian P. Russell, R.Ph., M.B.A. President, Institute for Continuing Healthcare Education Medical education companies must change the way they do business to meet the new guidelines an...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Extreme Makeover: The New Look for Needs Assessments and Outcomes Measurement

Needs Assessment Dixie Blankenship, Manager of the CME Program and Compliance Alicia Sutton, General Manager (Washington, D.C., office) Jeannine Murray, R.Ph., Managing Director (Indianapolis office) Deborah Wood, President and CEO Elizabeth Yarboro, Manager of CME Design and Development ...
By PharmaVoice Team • Jan. 2, 2008